Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...
A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...
Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...
ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...
BAAR, Switzerland, July 07, 2025--(BUSINESS WIRE)--CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.
Heart disease is the number-one killer of women, with over 60 million women (44%) in the U.S. living with some form of heart disease. There is one woman dying from heart disease every minute. The ...
VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), ...
Thousands of Oklahomans suffer from unexplained chest pain despite receiving normal heart results, health experts say, but a new diagnostic tool at OU Health could give patients some answers. OU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results